Spero Therapeutics, Inc. (SPRO)

NASDAQ: SPRO · Real-Time Price · USD

2.370

+0.010 (0.42%)

At close: Feb 11, 2026, 4:00 PM EST

2.370

0.00 (0.00%)

After-hours: Feb 11, 2026, 6:27 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Novel Treatments for Multi-drug Resistant Bacterial Infections	103.78M
Novel Treatments for Multi-drug Resistant Bacterial Infections Growth	93.95%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.